ATE451383T1 - Hochreines 17alfa-cyanomethyl-17beta-hydroxyöstra-4,9-dien 3-on und verfahren zu dessen synthese - Google Patents

Hochreines 17alfa-cyanomethyl-17beta-hydroxyöstra-4,9-dien 3-on und verfahren zu dessen synthese

Info

Publication number: ATE451383T1
Authority: AT; Austria
Prior art keywords: formula; diene; cyanomethyl; estra; hydroxy
Prior art date: 2005-12-05

Application number

AT06808800T

Other languages

English (en)

Inventor

Lajosne Dancsi

Sandor Maha

Antal Aranyi

Th Janos Horv

Original Assignee

Richter Gedeon Nyrt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-05

Filing date

2006-10-11

Publication date

2009-12-15

2006-10-11 Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt

2009-12-15 Application granted granted Critical

2009-12-15 Publication of ATE451383T1 publication Critical patent/ATE451383T1/de

Links

230000015572 biosynthetic process Effects 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
229960003309 dienogest Drugs 0.000 abstract 5
AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 4
239000004480 active ingredient Substances 0.000 abstract 3
XFFZLECPCHQJIR-BBCBXFPWSA-N (8r,9s,13s,14s)-3-methoxy-13-methyl-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-ol Chemical compound C1C[C@@H]2C(CC=C(C3)OC)=C3CC[C@H]2[C@@H]2CCC(O)[C@]21C XFFZLECPCHQJIR-BBCBXFPWSA-N 0.000 abstract 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
NSUVCVKCWGOYPV-VXNCWWDNSA-N (8r,9s,13s,14s)-3-methoxy-13-methyl-4,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-one Chemical compound C1C[C@@H]2C(CC=C(C3)OC)=C3CC[C@H]2[C@@H]2CCC(=O)[C@]21C NSUVCVKCWGOYPV-VXNCWWDNSA-N 0.000 abstract 1
OFIPMSSTKFSADG-UHFFFAOYSA-N [Li]CC#N Chemical compound [Li]CC#N OFIPMSSTKFSADG-UHFFFAOYSA-N 0.000 abstract 1
SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 abstract 1
239000000969 carrier Substances 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
238000010438 heat treatment Methods 0.000 abstract 1
239000012535 impurity Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000002953 preparative HPLC Methods 0.000 abstract 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 abstract 1
238000001953 recrystallisation Methods 0.000 abstract 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Lubricants (AREA)

AT06808800T 2005-12-05 2006-10-11 Hochreines 17alfa-cyanomethyl-17beta-hydroxyöstra-4,9-dien 3-on und verfahren zu dessen synthese ATE451383T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0501132A HUP0501132A2 (en)	2005-12-05	2005-12-05	17-alpha-cyanomethyl-17betha-hydroxyestra-4,9-diene-3-one of high purity and process for its production
PCT/HU2006/000091 WO2007066158A2 (en)	2005-12-05	2006-10-11	HIGH PURITY 17α-CYANOMETHYL-17β-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF

Publications (1)

Publication Number	Publication Date
ATE451383T1 true ATE451383T1 (de)	2009-12-15

Family

ID=89986433

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06808800T ATE451383T1 (de)	2005-12-05	2006-10-11	Hochreines 17alfa-cyanomethyl-17beta-hydroxyöstra-4,9-dien 3-on und verfahren zu dessen synthese

Country Status (22)

Country	Link
US (1)	US8314145B2 (de)
EP (1)	EP1963354B1 (de)
JP (1)	JP5399711B2 (de)
CN (1)	CN101360757B (de)
AT (1)	ATE451383T1 (de)
AU (1)	AU2006323005B2 (de)
BR (1)	BRPI0619428B8 (de)
CA (1)	CA2631748C (de)
CY (1)	CY1110063T1 (de)
DE (1)	DE602006011052D1 (de)
DK (1)	DK1963354T3 (de)
EA (1)	EA014558B1 (de)
ES (1)	ES2338047T3 (de)
HR (1)	HRP20100102T1 (de)
HU (1)	HUP0501132A2 (de)
IL (1)	IL191915A (de)
MX (1)	MX2008007243A (de)
PL (1)	PL1963354T3 (de)
PT (1)	PT1963354E (de)
SI (1)	SI1963354T1 (de)
UA (1)	UA91390C2 (de)
WO (1)	WO2007066158A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2378604T3 (es) *	2009-05-22	2012-04-16	HEYL Chemisch-Pharmazeutische Fabrik GmbH und Co. KG	Método para la síntesis de dienogest a partir de 3-metiléter de estrona
US20130041166A1 (en)	2010-04-20	2013-02-14	Lupin Limited	Process for the preparation of dienogest substantially free of impurities
CN101863947A (zh) *	2010-06-29	2010-10-20	沈阳药科大学	一种地诺孕素的合成方法
CN103304619B (zh) *	2013-06-08	2015-12-02	西藏海思科药业集团股份有限公司	一种地诺孕素化合物
HU230788B1 (en) *	2013-12-16	2018-05-02	Richter Gedeon Nyrt	Norsteroid intermediates and process for their preparation
WO2017064814A1 (ja) *	2015-10-16	2017-04-20	持田製薬株式会社	ジエノゲスト含有錠剤
WO2017064815A1 (ja) *	2015-10-16	2017-04-20	持田製薬株式会社	低用量薬物を含有する口腔内崩壊錠
CN110357937A (zh) *	2018-03-26	2019-10-22	华润紫竹药业有限公司	一种地诺孕素化合物
CN110655551A (zh) *	2019-09-23	2020-01-07	华润紫竹药业有限公司	一种地诺孕素药物单一新晶型及其制备方法
CN114736261A (zh) *	2022-05-17	2022-07-12	梯尔希（南京）药物研发有限公司	8,11-二烯地塞米松的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3391165A (en) *	1966-04-07	1968-07-02	Smith	Synthesis of gon-5(10)-enes
DE2718872A1 (de) *	1976-06-14	1977-12-22	Jenapharm Veb	Verfahren zur herstellung von neuen gona-4,9(10)-dienen
DD160418A1 (de) *	1979-05-22	1983-07-27	Kurt Ponsold	Verfahren zur herstellung von 17alpha-substituierten gona-4,9-dienen
WO1992000991A1 (de) *	1990-07-09	1992-01-23	Jenapharm Gmbh	VERFAHREN ZUR HERSTELLUNG VON UNGESÄTTIGTEN 17α-CYANOMETHYL-17β-HYDROXYSTEROIDEN
IL119649A (en)	1995-11-30	2002-03-10	Akzo Nobel Nv	Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
IT1318491B1 (it) *	2000-04-21	2003-08-25	Ind Chimica Srl	Processo per la preparazione di un precursore di tibolone e diestradiol derivati strutturalmente correlati.
ES2337521T3 (es) *	2006-02-17	2010-04-26	Janssen Pharmaceutica N.V.	Derivados esteroides 17-fosforados utilizados como moduladores del receptor de la progesterona.

2005
- 2005-12-05 HU HU0501132A patent/HUP0501132A2/hu unknown
2006
- 2006-10-11 UA UAA200808851A patent/UA91390C2/ru unknown
- 2006-10-11 DE DE602006011052T patent/DE602006011052D1/de active Active
- 2006-10-11 SI SI200630561T patent/SI1963354T1/sl unknown
- 2006-10-11 AT AT06808800T patent/ATE451383T1/de active
- 2006-10-11 MX MX2008007243A patent/MX2008007243A/es active IP Right Grant
- 2006-10-11 US US12/096,209 patent/US8314145B2/en active Active
- 2006-10-11 PT PT06808800T patent/PT1963354E/pt unknown
- 2006-10-11 AU AU2006323005A patent/AU2006323005B2/en active Active
- 2006-10-11 WO PCT/HU2006/000091 patent/WO2007066158A2/en not_active Ceased
- 2006-10-11 ES ES06808800T patent/ES2338047T3/es active Active
- 2006-10-11 HR HR20100102T patent/HRP20100102T1/hr unknown
- 2006-10-11 EA EA200801508A patent/EA014558B1/ru unknown
- 2006-10-11 CN CN2006800515980A patent/CN101360757B/zh active Active
- 2006-10-11 JP JP2008543921A patent/JP5399711B2/ja active Active
- 2006-10-11 DK DK06808800.4T patent/DK1963354T3/da active
- 2006-10-11 CA CA2631748A patent/CA2631748C/en active Active
- 2006-10-11 EP EP06808800A patent/EP1963354B1/de active Active
- 2006-10-11 BR BRPI0619428A patent/BRPI0619428B8/pt active IP Right Grant
- 2006-10-11 PL PL06808800T patent/PL1963354T3/pl unknown
2008
- 2008-06-03 IL IL191915A patent/IL191915A/en active IP Right Grant
2010
- 2010-01-29 CY CY20101100088T patent/CY1110063T1/el unknown

Also Published As

Publication number	Publication date
HRP20100102T1 (hr)	2010-04-30
EA200801508A1 (ru)	2008-10-30
BRPI0619428B1 (pt)	2021-02-17
PT1963354E (pt)	2010-01-06
IL191915A0 (en)	2008-12-29
WO2007066158A2 (en)	2007-06-14
MX2008007243A (es)	2008-10-22
ES2338047T3 (es)	2010-05-03
AU2006323005B2 (en)	2013-05-30
DK1963354T3 (da)	2010-04-12
BRPI0619428A2 (pt)	2011-10-04
WO2007066158A3 (en)	2007-08-09
EP1963354B1 (de)	2009-12-09
CN101360757A (zh)	2009-02-04
US8314145B2 (en)	2012-11-20
CN101360757B (zh)	2011-07-20
CA2631748C (en)	2013-12-03
HUP0501132A2 (en)	2007-06-28
US20080287404A1 (en)	2008-11-20
SI1963354T1 (sl)	2010-03-31
IL191915A (en)	2016-04-21
JP5399711B2 (ja)	2014-01-29
CY1110063T1 (el)	2015-01-14
AU2006323005A1 (en)	2007-06-14
PL1963354T3 (pl)	2010-05-31
BRPI0619428B8 (pt)	2021-05-25
EP1963354A2 (de)	2008-09-03
JP2009518377A (ja)	2009-05-07
UA91390C2 (en)	2010-07-26
DE602006011052D1 (de)	2010-01-21
CA2631748A1 (en)	2007-06-14
EA014558B1 (ru)	2010-12-30
HU0501132D0 (en)	2006-01-30

Legal Events

Date

Code

Title

Description

2010-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1963354

Country of ref document: EP

Publication	Publication Date	Title
IL191915A0 (en)	2008-12-29	High purity 17??-cyanomethyl-17??-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof
Suarez et al.	2003	Synthesis and study of novel fulleropyrrolidines bearing biologically active 1, 4-dihydropyridines
Plater et al.	2004	The CA. M lattice revisited. Gel formation from a linear bis-isocyanuric acid and 2-amino-4, 6-bis-(4-tert-butylphenylamino)-1, 3, 5-triazine
DE69703228T2 (de)	2001-02-22	Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon
EP3845521B1 (de)	2024-11-06	Syntheseverfahren für upadacitinib und zwischenprodukt davon
KR100917698B1 (ko)	2009-09-21	레트로졸의 제조를 위한 개선된 방법
JP3973941B2 (ja)	2007-09-12	δ−アミノペンタジエン酸エステル誘導体の製造方法
Deng et al.	2009	Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo [d] isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Campos et al.	1997	α-Iodination of enaminones with bis (pyridine) iodonium (I) tetrafluoroborate
HU216973B (hu)	1999-10-28	Eljárás imidazolszármazékok előállítására
WO2007144896A1 (en)	2007-12-21	A method of manufacture of letrozole
CN114890992A (zh)	2022-08-12	一种厄贝沙坦的杂质及其制备和检测方法以及厄贝沙坦的制备方法
EP2909224A2 (de)	2015-08-26	Verbessertes verfahren zur herstellung von fulvestrant
WO2007054964A2 (en)	2007-05-18	Process for the preparation of letrozole
JP2008511684A (ja)	2008-04-17	アナストロゾール中間体についての精製方法
Kumar et al.	2011	Synthesis and evaluation of some newer indole derivatives as anticonvulsant agents
RU2620084C1 (ru)	2017-05-23	Сульфаматы 2-этил-6-оксаэстра-1,3,5(10),8,14-пентаенов в качестве ингибиторов пролиферации опухолевых клеток MCF-7
CN113698409A (zh)	2021-11-26	一种多用途的二氮杂双环类化合物、制备方法及在合成药物中的应用
CN108658852A (zh)	2018-10-16	新化合物吗拉贝胺、其制备方法及用途
EP3383885B1 (de)	2021-10-13	Kristallisierung von 25-hydroxy-7-dehydrocholesterin
Katritzky et al.	1999	Direct Synthesis of a-(Benzotriazol-1-yl) alkyl Ethers
NO138147B (no)	1978-04-03	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 15alfa,16alfa-methylen-4-pregnener
SU812170A3 (ru)	1981-03-07	Способ получени -замещенныхАМидОВ 2,4-биС(бЕНзАМидО)-бЕНзОй-НОй КиСлОТы
He et al.	2006	Synthesis of tritium and deuterium labelled agmatine
Moniz et al.	1997	On the relocation of the amino functionality to the ethyl side chain in aminoglutethimide: Synthesis and aromatase‐inhibitory activity of 3‐(2′‐N, N‐diethyl‐amino) ethyl‐3‐phenylpiperidine‐2, 6‐dione